Holen Sie sich die Stockscreener-App
6.10
6.27%
0.36
Handel nachbörslich:
6.09
-0.010
-0.16%
Schlusskurs vom Vortag:
$5.74
Offen:
$5.51
24-Stunden-Volumen:
21,707
Relative Volume:
1.93
Marktkapitalisierung:
$84.71M
Einnahmen:
$58.42M
Nettoeinkommen (Verlust:
$2.43M
KGV:
36.66
EPS:
0.1664
Netto-Cashflow:
$5.64M
1W Leistung:
+3.92%
1M Leistung:
+0.33%
6M Leistung:
-10.69%
1J Leistung:
-31.38%
1-Tages-Spanne:
$5.50
$6.2302
1-Wochen-Bereich:
$5.50
$6.2302
52-Wochen-Spanne:
$5.50
$10.25
Champions Oncology Inc Stock (CSBR) Company Profile
Firmenname
Champions Oncology Inc
Sektor
Branche
Telefon
410-369-0365
Adresse
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.10 | 79.71M | 58.42M | 2.43M | 5.64M | 0.1664 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-12 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-11-18 | Eingeleitet | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten
Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business - MSN
Champions Oncology (CSBR) Earnings Transcript - The Globe and Mail
Champions Oncology (CSBR) Earnings Transcript - The Motley Fool
Champions Oncology, Inc. Q3 2026 Financial Report: Balance Sheet, Income Statement, and Key Financial Highlights - Minichart
Champions Oncology reports Q3 revenue of $16.6 million By Investing.com - Investing.com India
Champions Oncology reports Q3 revenue of $16.6 million - Investing.com South Africa
Earnings call transcript: Champions Oncology Q3 2026 misses EPS forecast, revenue grows - Investing.com
Barco Announces HDR by Barco is confirmed as a format for THE DEVIL WEARS PRADA 2, THE MANDALORIAN AND GROGU, and TOY STORY 5 – NEWSnet Michigan - michigan.newsnetmedia.com
Champions Oncology earnings missed by $0.04, revenue topped estimates - Investing.com Canada
American Properties Realty, Inc. Leadership Attends NAHB International Builders’ Show in Florida - michigan.newsnetmedia.com
John Lauer, EVP and CCO, Announces Retirement Plans - michigan.newsnetmedia.com
CHAMPIONS ONCOLOGY ($CSBR) Releases Q3 2026 Earnings - Quiver Quantitative
Champions Oncology Reports Revenue of $16.6 Million - marketscreener.com
Fund Flows: Is Champions Oncology Inc benefiting from innovation trendsBear Alert & Verified Chart Pattern Signals - baoquankhu1.vn
Tom Brady Retirement Struggle Explains Midlife Male Identity Crisis: New Guide - michigan.newsnetmedia.com
Epson Robots to Showcase Scalable Retail Automation at Shoptalk Spring 2026 - michigan.newsnetmedia.com
Sir Nick Clegg appointed to Efekta Education Group Advisory Board - michigan.newsnetmedia.com
Momentum Shift: How does Champions Oncology Inc. score in quality rankingsEarnings Recap Report & Low Volatility Stock Recommendations - baoquankhu1.vn
International Women’s Day Highlights 2026: Honoring Women in Oncology - Oncodaily
Can SUPV stock sustain double digit ROEAnalyst Upgrade & AI Powered Market Entry Strategies - Naître et grandir
Aug Decliners: Is Champions Oncology Inc showing insider buyingEarnings Beat & Real-Time Buy Signal Alerts - baoquankhu1.vn
Can Atea Pharmaceuticals Inc stock double in the next year2025 Winners & Losers & Consistent Income Trade Ideas - baoquankhu1.vn
Champions Oncology Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026 - Corsicana Daily Sun
CSBR SEC FilingsChampions Oncolo 10-K, 10-Q, 8-K Forms - Stock Titan
Behavioral Patterns of CSBR and Institutional Flows - Stock Traders Daily
IMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
FGBI PE Ratio & Valuation, Is FGBI Overvalued - Intellectia AI
SFBC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
NOTV Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is the earnings history of CREVCEO Change & Low Drawdown Trading Techniques - mfd.ru
Whale Trades: Will Champions Oncology Inc outperform the market in YEARLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
OKYO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
EV Market: Should value investors consider CNVSTrade Signal Summary & Stock Market Timing Techniques - baoquankhu1.vn
Patient Derived Xenografts/PDX Models Market Research and Global Forecast Report 2025-2030 - GlobeNewswire
Insider Sell: Is Yunhong Green CTI Ltd stock forming a cup and handleWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IPO Launch: Is Hovnanian Enterprises Inc likely to announce a buybackRecession Risk & Reliable Breakout Stock Forecasts - baoquankhu1.vn
START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit - Morningstar
Analyst Calls: What are the risks of holding GLOBALFOUNDRIES IncJuly 2025 Recap & AI Driven Price Predictions - baoquankhu1.vn
Is Champions Oncology Inc. benefiting from innovation trendsJuly 2025 Drop Watch & Breakout Confirmation Alerts - mfd.ru
Is Champions Oncology Inc. stock supported by strong fundamentals2025 Geopolitical Influence & Technical Pattern Recognition Alerts - mfd.ru
Aug Gainers: Is now the right time to enter Cadre Holdings IncQuarterly Portfolio Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
(CSBR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Trading Recap: How does Fifth Third Bancorp compare to its peersJuly 2025 Chart Watch & Real-Time Volume Triggers - baoquankhu1.vn
Patterns Watch: How does FBRX compare to its peersBear Alert & Accurate Entry/Exit Alerts - baoquankhu1.vn
LCUT PE Ratio & Valuation, Is LCUT Overvalued - Intellectia AI
Is Champions Oncology Inc. stock resilient to inflationQuarterly Trade Summary & High Accuracy Investment Entry Signals - mfd.ru
Optex Systems Q1 Earnings Highlights - Intellectia AI
A activity2025 Price Action Summary & Verified Swing Trading Watchlist - mfd.ru
What are analysts’ price targets for Champions Oncology Inc.July 2025 Drop Watch & Free Growth Oriented Trading Recommendations - mfd.ru
Can FTCI stock attract ESG capital inflows2025 Price Action Summary & Fast Gain Swing Alerts - mfd.ru
Finanzdaten der Champions Oncology Inc-Aktie (CSBR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):